Form 483

University of Texas Southwestern Medical Center, The Form 483, 2017-08-02

FDA issued a Form 483 to University of Texas Southwestern Medical Center, The on 2017-08-02 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

University of Texas Southwestern Medical Center, The · Dallas, United States · Issued August 2, 2017

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Aug 2017
21 CFR 212.20(b)

Examine, approve or reject

Cited by Hala L Selby

2 Aug 2017
21 CFR 212.30(a)

Prevention of contamination

Cited by Hala L Selby

2 Aug 2017
21 CFR 212.60(b)

Testing Procedures- Conformance to Standards

Cited by Hala L Selby

2 Aug 2017
21 CFR 212.60(g)(3)

Record of all test data

Cited by Hala L Selby

2 Aug 2017
21 CFR 212.71(b)

Documentation of Non-Conforming Product Investigation

Cited by Hala L Selby

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.20(b)Cited across public-safe Form 483 observations1x
21 CFR 212.30(a)Cited across public-safe Form 483 observations1x
21 CFR 212.60(b)Cited across public-safe Form 483 observations1x
21 CFR 212.60(g)(3)Cited across public-safe Form 483 observations1x
21 CFR 212.71(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere